Center for Scientific Review; Notice of Closed Meetings, 14117-14118 [2016-05963]
Download as PDF
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Notices
notify interested persons regarding their
request to speak by April 26, 2016.
Closed Committee Deliberations: On
May 11, 2016, from 3:25 p.m. to 4:30
p.m., the meeting will be closed to
permit discussion where disclosure
would constitute a clearly unwarranted
invasion of personal privacy (5 U.S.C.
552b(c)(6)). The committee will discuss
the report of the intramural research
program and make recommendations
regarding personnel staffing decisions.
Persons attending FDA’s advisory
committee meetings are advised that the
Agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with disabilities.
If you require accommodations due to a
disability, please contact Sujata Vijh at
least 7 days in advance of the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: March 11, 2016.
Jill Hartzler Warner,
Associate Commissioner for Special Medical
Programs.
[FR Doc. 2016–05930 Filed 3–15–16; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Service
Administration
mstockstill on DSK4VPTVN1PROD with NOTICES
Council on Graduate Medical
Education; Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Public Law 92–463), notice is hereby
given of the following meeting:
Name: Council on Graduate Medical
Education (COGME).
Dates and Times: April 7, 2016 (Day
1—8:30 a.m.–5:00 p.m., EST). April 8,
2016 (Day 2—8:30 a.m.–3:00 p.m., EST).
Place: In-Person Meeting with
Webinar/Conference Call Component,
5600 Fishers Lane, Room 5A02,
Rockville, MD 20857.
Status: The meeting will be open to
the public.
Purpose: The COGME provides advice
and recommendations to the Secretary
VerDate Sep<11>2014
18:11 Mar 15, 2016
Jkt 238001
of the Department of Health and Human
Services (the Secretary) on a range of
issues including the supply and
distribution of physicians in the United
States, current and future physician
shortages or excesses, issues relating to
foreign medical school graduates, the
nature and financing of medical
education training, and the
development of performance measures
and longitudinal evaluation of medical
education programs. COGME’s reports
are submitted to the Secretary and
ranking members of the Senate
Committee on Health, Education, Labor,
and Pensions and the House of
Representatives Committee on Energy
and Commerce.
COGME will start its official meeting
at 8:30 a.m. each day. Discussion will
focus on finalizing the draft of COGME’s
Diversity Resource Paper and the
development of a vision, mission, and
guiding principles for graduate medical
education.
Agenda: The COGME agenda will be
available 2 days prior to the meeting on
the HRSA Web site at https://
www.hrsa.gov/advisorycommittees/
bhpradvisory/cogme/.
SUPPLEMENTARY INFORMATION: Requests
to make oral comments or provide
written comments to the COGME should
be sent to Dr. Joan Weiss, Designated
Federal Official, using the address and
phone number below. Individuals who
plan to participate on the conference
call and webinar should notify Dr.
Weiss at least 3 days prior to the
meeting, using the address and phone
number below. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the contact person listed below at
least 10 days prior to the meeting.
Members of the public will have the
opportunity to provide comments.
Interested parties should refer to the
meeting subject as the HRSA Council on
Graduate Medical Education.
• The conference call-in number is 1–
800–619–2521. The passcode is
9271697.
• The webinar link is https://
hrsa.connectsolutions.com/cogmecouncil/.
FOR FURTHER INFORMATION CONTACT:
Anyone requesting information
regarding the COGME should contact
Dr. Joan Weiss, Designated Federal
Official within the Bureau of Health
Workforce, Health Resources and
Services Administration, in one of three
ways: (1) Send a request to the following
address: Dr. Joan Weiss, Designated
Federal Official, Bureau of Health
Workforce, Health Resources and
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
14117
Services Administration, 5600 Fishers
Lane, Room 15N39, Rockville, Maryland
20857; (2) call (301) 443–0430; or (3)
send an email to jweiss@hrsa.gov.
Jackie Painter,
Director, Division of the Executive Secretariat.
[FR Doc. 2016–05877 Filed 3–15–16; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Integrated
Physiology of Obesity.
Date: March 30, 2016.
Time: 12:00 p.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Raul Rojas, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive
Room 6185, Bethesda, MD 20892, (301) 451–
6319, rojasr@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Urological
Applications.
Date: April 1, 2016.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Ryan G. Morris, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4205,
MSC 7814, Bethesda, MD 20892, 301–435–
1501, morrisr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Pediatric
AIDS.
Date: April 1, 2016.
Time: 12:30 p.m. to 2:30 p.m.
E:\FR\FM\16MRN1.SGM
16MRN1
mstockstill on DSK4VPTVN1PROD with NOTICES
14118
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Jose H. Guerrier, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, 301–435–
1137, guerriej@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neurogenesis During Development
and in Adulthood.
Date: April 8, 2016.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Nicholas Gaiano, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5178,
MSC 7844, Bethesda, MD 20892–7844, 301–
435–1033, gaianonr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Hematology and Vascular Biology.
Date: April 11–12, 2016.
Time: 10:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Anshumali Chaudhari,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4124,
MSC 7802, Bethesda, MD 20892, 301–435–
1210, chaudhaa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA RM13–
007: New Innovator Award.
Date: April 13–14, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Baltimore—Inner
Harbor, 222 St Paul Place, Baltimore, MD
21202.
Contact Person: Rajiv Kumar, Ph.D., Chief,
MOSS IRG, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4216, MSC 7802, Bethesda, MD
20892, 301–435–1212, kumarra@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 11, 2016.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–05963 Filed 3–15–16; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:11 Mar 15, 2016
Jkt 238001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Clinical Research in HIV/HLB Diseases.
Date: Date: April 12, 2016.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Dupont Circle Hotel, 1500 New
Hampshire Ave. NW., Washington, DC
20036.
Contact Person: Stephanie L. Constant,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute, 6701 Rockledge
Drive, Room 7189, Bethesda, MD 20892, 301–
443–8784, constantsl@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: March 11, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–05965 Filed 3–15–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; NIH Information
Collection Forms To Support Genomic
Data Sharing for Research Purposes
(OD)
Summary: Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH), has submitted
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in
the Federal Register on December 1,
2015, page 75120 and allowed 60 days
for public comment. A public comment
was received. The purpose of this notice
is to allow an additional 30 days for
public comment. The Office of the
Director (OD), National Institutes of
Health, may not conduct or sponsor,
and the respondent is not required to
respond to, an information collection
that has been extended, revised, or
implemented on or after October 1,
1995, unless it displays a currently valid
OMB control number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
For Further Information Contact: To
obtain a copy of the data collection
plans and instruments, or request more
information on the proposed project,
contact: Dina Paltoo, Office of Science
Policy, 6705 Rockledge Drive or call
non-toll-free number (301) 496–9838 or
Email your request, including your
address to: GDS@mail.nih.gov. Formal
requests for additional plans and
instruments must be requested in
writing.
Proposed Collection: Forms to
Support Genomic Data Sharing for
Research Purposes, 0925–0670,
Expiration Date 03/31/2016—
REVISION, Office of the Director, OD,
National Institutes of Health (NIH).
Need and Use of Information
Collection: Sharing research data
supports the NIH mission and is
essential to facilitate the translation of
research results into knowledge,
products, and procedures that improve
human health. The NIH has
longstanding policies to make a broad
range of research data, including
genomic data, publicly available in a
timely manner from the research
activities that it funds. Genomic
research data sharing is an integral
element of the NIH mission as it
facilitates advances in our
understanding of factors that influence
health and disease, while also providing
E:\FR\FM\16MRN1.SGM
16MRN1
Agencies
[Federal Register Volume 81, Number 51 (Wednesday, March 16, 2016)]
[Notices]
[Pages 14117-14118]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-05963]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Integrated Physiology of Obesity.
Date: March 30, 2016.
Time: 12:00 p.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Raul Rojas, Ph.D., Scientific Review Officer,
Center for Scientific Review, 6701 Rockledge Drive Room 6185,
Bethesda, MD 20892, (301) 451-6319, rojasr@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Urological Applications.
Date: April 1, 2016.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Ryan G. Morris, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4205, MSC 7814, Bethesda, MD
20892, 301-435-1501, morrisr@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Pediatric AIDS.
Date: April 1, 2016.
Time: 12:30 p.m. to 2:30 p.m.
[[Page 14118]]
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Jose H. Guerrier, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD
20892, 301-435-1137, guerriej@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Neurogenesis During Development and in
Adulthood.
Date: April 8, 2016.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Nicholas Gaiano, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5178, MSC 7844, Bethesda, MD
20892-7844, 301-435-1033, gaianonr@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Hematology and Vascular Biology.
Date: April 11-12, 2016.
Time: 10:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Anshumali Chaudhari, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4124, MSC 7802, Bethesda, MD
20892, 301-435-1210, chaudhaa@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA RM13-007: New Innovator Award.
Date: April 13-14, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites Baltimore--Inner Harbor, 222 St Paul
Place, Baltimore, MD 21202.
Contact Person: Rajiv Kumar, Ph.D., Chief, MOSS IRG, Center for
Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 4216, MSC 7802, Bethesda, MD 20892, 301-435-1212,
kumarra@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: March 11, 2016.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-05963 Filed 3-15-16; 8:45 am]
BILLING CODE 4140-01-P